PMID: 22359961Mar 1, 2012Paper

The QIP: will it improve dialysis care? An overview

Nephrology News & Issues
Steven FishbaneNaveed N Masani

Abstract

The Centers for Medicare & Medicaid Services End-Stage Renal Disease Quality Incentive Program is a pay-for-performance initiative that imposes dialysis payment reductions of up to 2% for suboptimal quality. In payment years 2012 and 2013 the methodology is simple, a point system based on performance in dialysis adequacy and anemia. In payment year 2014 (performance period begins Jan. 1, 2012) the QIP changes substantially, with a methodology that more closely resembles the Medicare Hospital Inpatient Value-Based Purchasing Program. Succeeding with the QIP will require both providing high quality care for a wider variety of measures, and a clear and complete understanding of the program structure and the new scoring methodology. In this review we discuss the QIP, with a comprehensive explanation of measures and scoring procedure.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Steven Fishbane, Azzour Hazzan
Hospital Case Management : the Monthly Update on Hospital-based Care Planning and Critical Paths
Hospital Case Management : the Monthly Update on Hospital-based Care Planning and Critical Paths
Hospital Case Management : the Monthly Update on Hospital-based Care Planning and Critical Paths
© 2022 Meta ULC. All rights reserved